Cholera Vaccine Suppliers & Bulk Manufacturers
Available Forms: Oral live attenuated vaccine (liquid suspension), Inactivated killed vaccine (injectable)
Available Strengths: 2.0 mL
Reference Brands: Dukoral, Shanchol(EU)
Category:
Vaccines
Cholera vaccines stimulate immunity by introducing inactivated Vibrio cholerae bacteria, prompting the body to produce protective antibodies. They effectively prevent cholera infection, reduce severity, and curb transmission. Benefits include rapid protection, support for outbreak control, and safeguarding travelers and at-risk populations from cholera’s severe dehydration and diarrhea.
Cholera Vaccine is available in Oral live attenuated vaccine (liquid suspension), Inactivated killed vaccine (injectable)
and strengths such as 2.0 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cholera Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cholera Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cholera vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. In the US, regulatory approval involves rigorous clinical evaluation, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and extensive audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective cholera vaccines essential for preventing outbreaks and protecting travelers and vulnerable populations worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing